Hypoxia-inducible factor HIF-1α: pharmacogenetic perspective for bevacizumab therapy individualization

被引：0

作者：

Tauser, Roxana-Georgiana ^{[1
]}

Zugun-Eloae, Florin ^{[2
]}

Jitaru, Daniela ^{[3
]}

Carasevici, Eugen ^{[2
]}

机构：

[1] Gr T Popa Univ Med & Pharm Iasi, Dept Med Chem, Sch Pharm, Iasi 700115, Romania

[2] Gr T Popa Univ Med & Pharm Iasi, Sch Med, Dept Immunol, Iasi 700115, Romania

[3] St Spiridon Univ Emmergency Hosp Iasi, Iasi, Romania

来源：

REVISTA ROMANA DE MEDICINA DE LABORATOR | 2009年 / 16卷 / 03期

关键词：

pharmacogenetics; bevacizumab; hypoxia inducible factor; cancer; CIRCULATING ENDOTHELIAL-CELLS; METASTATIC COLORECTAL-CANCER; BREAST-CANCER; POLYMORPHISMS; ANGIOGENESIS; CHALLENGES; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; GENE;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Pharmacogenetics of innovative angiogenic-targeted monoclonal antibody therapy, yet in its infancy, will be crucial in treatment individualization according to the genetic profile of each patient and molecular features of tumors. Bevacizumab (Avastin) specifically targets the key promotor of angiogenesis - vascular endothelial growth factor (VEGF), whose transcription is critically regulated by hypoxia-inducible factor HIF-1 alpha. The present paper points out the clinical relevance of HIF-1 alpha common genetic polymorphisms to the inter-individual variability in response to anti-VEGF-targeted monoclonal antibody therapeutic regimens, with special reference to colorectal cancer.

引用

页码：7 / 12

页数：6

共 50 条

[21] Identification of heat shock protein 60 as the regulator of the hypoxia-inducible factor subunit hif-1α
Nakamura, H., 2012, Walter de Gruyter GmbH (84) : 2325 - 2337
[22] Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism
Sharma, Abhilasha
Sinha, Sonam
Shrivastava, Neeta
FRONTIERS IN GENETICS, 2022, 13
[23] Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1
Miyazawa, Masaki
Yasuda, Masanori
Fujita, Mariko
Hirasawa, Takeshi
Kajiwara, Hiroshi
Hirabayashi, Kenichi
Ogane, Naoki
Shimizu, Michio
Asanuma, Hideki
Murakami, Masaru
Takekoshi, Susumu
Mikami, Mikio
Osamura, R. Yoshiyuki
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (06) : 789 - 796
[24] Molecular characterization of hypoxia and hypoxia-inducible factor 1 alpha (HIF-1α) from Taiwan voles (Microtus kikuchii)
Jiang, Yi-Fan
Chou, Chung-Hsi
Lin, En-Chung
Chiu, Chih-Hsien
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 2011, 158 (02): : 183 - 188
[25] Hypoxia-inducible factor-1 (HIF-1)-independent microvascular angiogenesis in the aged rat brain
Ndubuizu, Obinna I.
Tsipis, Constantinos P.
Li, Ang
Lamanna, Joseph C.
BRAIN RESEARCH, 2010, 1366 : 101 - 109
[26] Associations between hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms and risk of developing breast cancer
Naidu, R.
Har, Y. C.
Taib, N. A.
NEOPLASMA, 2009, 56 (05) : 441 - 447
[27] Regulation of hypoxia-inducible factor 1 (HIF-1) by nitric oxide in oral squamous cell carcinoma
Brennan, PA
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2005, 87 (03) : 153 - 158
[28] Involvement of hypoxia-inducible factor-1α (HIF-1α) in inhibition of benzene on mouse hematopoietic system
Meng, Xing
Zhang, Juan
Yin, Lihong
Pu, Yuepu
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2016, 79 (9-10): : 402 - 406
[29] Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions
Mandl, Markus
Kapeller, Barbara
Lieber, Roman
Macfelda, Karin
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (01) : 166 - 172
[30] Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)
Klabatsa, A
Sheaff, MT
Steele, JPC
Evans, MT
Rudd, RM
Fennell, DA
LUNG CANCER, 2006, 51 (01) : 53 - 59

← 1 2 3 4 5 →